You are here

Article Text

Article menu
Download PDFPDF
Colorectal cancer
Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology
  1. P A Bampton1,
  2. J J Sandford1,
  3. S R Cole2,
  4. A Smith3,
  5. J Morcom3,
  6. B Cadd3,
  7. G P Young4
  1. 1Department of Gastroenterology and Hepatology, Flinders Medical Centre, Australia
  2. 2Department of Medicine, Flinders University of South Australia, Australia, and Division of Medicine, Repatriation General Hospital Daw Park, Australia
  3. 3Division of Medicine, Repatriation General Hospital Daw Park, Australia
  4. 4Department of Gastroenterology and Hepatology, Flinders Medical Centre, Australia, and Department of Medicine, Flinders University of South Australia, Australia
  1. Correspondence to:
    Dr P Bampton
    Department of Gastroenterology and Hepatology, Flinders Medical Centre, Bedford Pk 5042, South Australia; peter.bampton{at}flinders.edu.au

Abstract

Background: Colonoscopic based surveillance is recommended for patients at increased risk of colorectal cancer. The appropriate interval between surveillance colonoscopies remains in debate, as is the “miss rate” for colorectal cancer within such screening programmes.

Aims: The main aim of this study was to determine whether a one-off interval faecal occult blood test (FOBT) facilitates the detection of significant neoplasia within a colonoscopic based surveillance programme. Secondary aims were to determine if invitees were interested in participating in interval screening, and to determine whether interval lesions were missed or whether they developed rapidly since the previous colonoscopy

Patients: Patients enrolled in a colonoscopic based screening programme due to a personal history of colorectal neoplasia or a significant family history.

Methods: Patients within the screening programme were invited to perform an immunochemical FOBT (Inform). A positive result was followed by colonoscopy; significant neoplasia was defined as colorectal cancer, adenomas either ⩾10 mm or with a villous component, high grade dysplasia, or multiplicity (⩾3 adenomas). Participation rates were determined for age, sex, and socioeconomic subgroups. Colonoscopy recall databases were examined to determine the interval between previous colonoscopy and FOBT offer, and correlations between lesion characteristics and interval time were determined.

Results: A total of 785 of 1641 patients invited (47.8%) completed an Inform kit. A positive result was recorded for 57 (7.3%). Fifty two of the 57 test positive patients completed colonoscopy; 14 (1.8% of those completing the FOBT) had a significant neoplastic lesion. These consisted of six colorectal cancers and eight significant adenomas.

Conclusions: A one off immunochemical faecal occult blood test within a colonoscopy based surveillance programme had a participation rate of nearly 50% and appeared to detect additional pathology, especially in patients with a past history of colonic neoplasia.

  • FOBT, faecal occult blood test
  • FMC, Flinders Medical Centre
  • RGHDP, Repatriation General Hospital Daw Park
  • colorectal cancer
  • surveillance
  • faecal occult blood
  • colonoscopy

https://doi.org/10.1136/gut.2004.043786

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Conflict of interest: None declared.

    Linked Articles

    • Digest
      Digest
      Robin Spiller
      Gut 2005; 54 735-735 Published Online First: 11 May 2005.